Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
The state's first patient portal has officially entered development, and the e-health firm leading the effort said that a former WebMD executive joined its board.
Dorothy Gemmell, who headed sales and sales operations at the portal, will take the reins at Havas Life New York.
MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.
WebMD is laying off 14% of its workforce in hopes of saving $45 million to offset revenue losses from an ongoing advertising slump that's plagued the portal throughout 2012.
WebMD had to go all the way up to 42nd Street to find its new CEO, Pfizer honcho Cavan Redmond. He brings a keen understanding of the site's biopharma industry advertisers, and he'll need it as the portal looks to shore up flagging ad sales on the consumer side of its business
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
Healthcare Q&A site Sharecare is buying RealAge from Hearst for an undisclosed sum, the companies said.
WebMD scrapped plans for a possible sale and announced that president and CEO Wayne Gattinella is stepping down after 11 years in that role.
WebMD's talks with private equity firms come amid an advertising slump, and going private could buy the firm time to retool its business model while insulating it from activist investors like Carl Icahn.
This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled